It was previously presented that CL GBM is characterized by EGFR amplification and wild-type TP53, whereas PN is characterized by both IDH1 and TP53 mutations and PDGFRA amplification [22]. This evidence concerns the gene PDGFRA and poikiloderma with neutropenia.